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Use of machine learning to analyse
routinely collected intensive care unit data:
a systematic review
Duncan Shillan1,2, Jonathan A. C. Sterne1,2, Alan Champneys3 and Ben Gibbison1,4,5*
Abstract
Background: Intensive care units (ICUs) face financial, bed management, and staffing constraints. Detailed data
covering all aspects of patients’ journeys into and through intensive care are now collected and stored in electronic
health records: machine learning has been used to analyse such data in order to provide decision support to clinicians.
Methods: Systematic review of the applications of machine learning to routinely collected ICU data. Web of Science
and MEDLINE databases were searched to identify candidate articles: those on image processing were excluded. The
study aim, the type of machine learning used, the size of dataset analysed, whether and how the model was validated,
and measures of predictive accuracy were extracted.
Results: Of 2450 papers identified, 258 fulfilled eligibility criteria. The most common study aims were predicting
complications (77 papers [29.8% of studies]), predicting mortality (70 [27.1%]), improving prognostic models (43
[16.7%]), and classifying sub-populations (29 [11.2%]). Median sample size was 488 (IQR 108–4099): 41 studies
analysed data on > 10,000 patients. Analyses focused on 169 (65.5%) papers that used machine learning to
predict complications, mortality, length of stay, or improvement of health. Predictions were validated in 161
(95.2%) of these studies: the area under the ROC curve (AUC) was reported by 97 (60.2%) but only 10 (6.2%)
validated predictions using independent data. The median AUC was 0.83 in studies of 1000–10,000 patients,
rising to 0.94 in studies of > 100,000 patients. The most common machine learning methods were neural networks
(72 studies [42.6%]), support vector machines (40 [23.7%]), and classification/decision trees (34 [20.1%]). Since 2015
(125 studies [48.4%]), the most common methods were support vector machines (37 studies [29.6%]) and random
forests (29 [23.2%]).
Conclusions: The rate of publication of studies using machine learning to analyse routinely collected ICU data is
increasing rapidly. The sample sizes used in many published studies are too small to exploit the potential of these
methods. Methodological and reporting guidelines are needed, particularly with regard to the choice of method and
validation of predictions, to increase confidence in reported findings and aid in translating findings towards routine use
in clinical practice.
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Key messages
Publication of papers reporting the use of machine
learning to analyse routinely collected ICU data is in-
creasing rapidly: around half of the identified studies
were published since 2015.
Machine learning methods have changed over time.
Neural networks are being replaced by support vector
machines and random forests.
The majority of published studies analysed data on
fewer than 1000 patients. Predictive accuracy increased
with increasing sample size.
Reporting of the validation of predictions was variable
and incomplete—few studies validated predictions using
independent data.
Methodological and reporting guidelines may increase
confidence in reported findings and thereby facilitate the
translation of study findings towards routine use in
clinical practice.
Background
Intensive care units (ICUs) face financial, bed manage-
ment, and staffing constraints among others. Efficient
operation in the light of these limits is difficult because
of their multidimensional and interconnected nature [1].
Extremely detailed data covering all aspects of patients’
journeys into and through intensive care are now col-
lected and stored in electronic health records (EHRs).
Data that are typically available in these EHRs include
demographic information, repeated physiological mea-
surements, clinical observations, laboratory test results,
and therapeutic interventions. Such detailed data offer
the potential to provide improved prediction of out-
comes such as mortality, length of stay, and complica-
tions, and hence improve both the care of patients and
the management of ICU resources [2–4].
Machine learning is a form of artificial intelligence
(AI) in which a model learns from examples rather than
pre-programmed rules. Example inputs and output for a
task are provided to ‘the machine’ and, using learning al-
gorithms, a model is created so that new information
can be interpreted. Machine learning approaches can
provide accurate predictions based on large, structured
datasets extracted from EHRs [5, 6]. There have been
rapid developments in machine learning methodology,
but many methods still require large datasets to model
complex and non-linear effects, and thereby improve on
prediction rules developed using standard statistical
methods [6–8]. Papers describing applications of ma-
chine learning to routinely collected data are published
regularly [7], but there is no recent systematic review
summarizing their characteristics and findings [9]. We
systematically reviewed the literature on uses of machine
learning to analyse routinely collected ICU data with a
focus on the purposes of the application, type of machine
learning methodology used, size of the dataset, and accu-
racy of predictions.
Methods
Systematic review design, definitions, and inclusion/
exclusion criteria
Search strategy
Candidate articles were identified from searches of Web
of Science and MEDLINE. There was no restriction on
the publication date, but only articles written in English
were included. Two searches connected with an ‘AND’
statement were used—one to capture applications of
artificial intelligence and the other to capture the ICU
setting. Searches for artificial intelligence used the fol-
lowing terms: ‘Machine Learning’, ‘Artificial Intelligence’,
‘Deep Learning’, ‘Neural Network’, ‘Support vector ma-
chine’, ‘Prediction Network’, ‘Forecast Model’, ‘Data min-
ing’, ‘Supervised Learning’, and ‘Time series prediction’.
Searches for the applications of artificial intelligence use
the following terms: ‘Cardiac Intensive Care Unit’, ‘CICU’,
‘ICU’, ‘Coronary Care’, ‘Critical Care’, ‘High Dependency’,
and ‘HDU’. The search terms were made in an iterative
process, initially using subject headings from citation
indexes and text word searches for machine learning
(e.g. ‘Artificial Intelligence/or Machine Learning/’,
‘Pattern Recognition, Automated/’, and ‘Machine lear-
ning.tw’, ‘Artificial intelligence.tw’, ‘Deep learning.tw’,
‘Supervised learning.tw’ respectively). The first 30 rele-
vant papers were extracted and mined for specific
terms (e.g. ‘Prediction network.tw’, ‘Support vector
machine?.tw’, ‘Demand Forecasting.tw.’). The search
was run again with these terms included, and the first
30 new relevant papers were extracted and mined for
specific terms. These were included in the search
terms to generate the final list of search terms (see
Additional file 1). Review papers were set aside for
separate analysis.
Eligibility criteria
Eligible papers (1) used machine learning or artificial
intelligence (AI), defined as any form of automated stat-
istical analysis or data science methodology; (2) analysed
routinely collected data that were generated as part of
patients’ standard care pathway in any hospital world-
wide; (3) analysed data collected in the ICU, defined as
an area with a sole function to provide advanced moni-
toring or support to single or multiple body systems;
and (4) were published in a scientific journal or confer-
ence proceeding when the proceeding detailed the full
study. Studies from all ICUs were eligible, regardless of
specialty. There was no limit on the age of included pa-
tients. The following types of study were excluded: (1)
use of machine learning to process or understand med-
ical images; (2) studies that focused on text mining; (3)
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analyses of novel research data rather than routinely
collected data; (4) studies that implemented additional
data collection techniques beyond hospitals’ routine sys-
tems; (5) studies based on data from a general medicine
ward, coronary care unit, operating theatre or post-an-
aesthetic care unit, or emergency room; (6) conference
abstracts and proprietary machine learning systems.
Papers describing reviews of machine learning based on
ICU data were also retrieved.
Study selection
Details of papers were uploaded to EndNote X8 (Clarivate
Analytics, Philadelphia, PA, USA), and duplicates were
removed using EndNote’s duplicate identification tool.
One author (DS) screened the titles and abstracts and
retrieved the full text of papers judged to be potentially
eligible for the review. Final decisions about eligibility,
based on reading the full text of the manuscripts, were
made by one author (DS), with a randomly selected subset
checked by two further authors (BG and JS). Conflicts
were resolved by consensus. An additional file provides a
full bibliography (see Additional file 2).
Review process and data extraction
The study characteristics to be extracted, and their defi-
nitions and categories, were decided iteratively following
study of 40 eligible papers. We extracted information on
the following study features: (1) aim (categorized as im-
proving prognostic models, classifying sub-populations,
determining physiological thresholds of illness, predict-
ing mortality, predicting length of stay, predicting com-
plications, predicting health improvement, detecting
spurious values, alarm reduction, improving upon previ-
ous methods (with details) and other (with details)); (2)
type of machine learning (categorized as classification/
decision trees, naïve Bayes/Bayesian networks, fuzzy logic,
Gaussian process, support vector machine, random forest,
neural network, superlearner, not stated and other (with
details)). All types of machine learning used were re-
corded; (3) dataset size (the number of patients, episodes
or samples analysed); (4) whether the study used data
from the publicly available Medical Information Mart for
Intensive Care II/III (MIMIC-II/III), which includes
deidentified health data on around 40,000 patients treated
at the Beth Israel Deaconess Medical Center between
2001 and 2012 [10]; (5) method used to validate predic-
tions (categorized as independent data, randomly selected
subset with leave-P-out (P recorded), k-fold cross-valid-
ation (k recorded), randomly selected subset, other (with
details), no validation). For studies that validated results
for multiple machine learning techniques, we recorded
the method corresponding to the most accurate approach.
For studies that dichotomized length of stay in order to
validate predictions, we recorded the threshold as the
highest length of stay in the lower-stay group; (6) meas-
ure of predictive accuracy (area under the receiver op-
erator characteristic (ROC) curve (AUC): proportion of
subjects correctly classified, sensitivity, and specificity).
Each measure reported was recorded. When measures
of predictive accuracy were recorded for multiple machine
learning techniques, we recorded the measures for the
most accurate approach. For multiple outcomes, we re-
corded the measures corresponding to the longest-term
outcome. When multiple validation datasets were used, we
recorded the measures for the most accurate approach; (7)
reporting of results from standard statistical methods such
as linear regression and logistic regression. We recorded
the method and the corresponding measures of accuracy,
using the same rules as described above when more than
one result was reported. In response to a suggestion from a
peer reviewer, we recorded whether papers reported on
calibration and, if so, the method that was used.
Risk of bias was not assessed in the included studies
because the purpose of our review was descriptive—the
aim was not to draw conclusions about the validity of es-
timates of predictive accuracy from the different studies.
The size of dataset analysed was tabulated according to
the study aims. Analyses were restricted to studies that
used machine learning to predict complications, mortality,
length of stay, or health improvement. The size of dataset
according to the type of machine learning, the approach
to validation according to outcome predicted, and the
measure of predictive accuracy according to outcome pre-
dicted were tabulated. The distribution of AUC according
to the number of patients analysed and outcome predicted
was plotted, along with the number of papers published
according to the type of machine learning and year of
publication.
Results
Identification of eligible studies
Two thousand eighty-eight papers were identified through
Web of Science and 773 through MEDLINE. After dupli-
cates were removed, the titles and abstracts of 2450
unique papers were screened, of which 2023 papers were
classified as ineligible. Of 427 papers for which the full
text was reviewed, 169 were found to be ineligible, mainly
because they did not use machine learning or did not
analyse routinely collected ICU data. The review therefore
included 258 papers (Fig. 1). MIMIC-II/III data were used
in 63 (24.4%) of these studies.
Purpose of machine learning in the ICU
The most common study aims were predicting complica-
tions (77 papers [29.8% of studies]), predicting mortality
(70 [27.1%]), improving prognostic models (43 [16.7%]),
and classifying sub-populations (29 [11.2%]) (Table 1).
The median sample size across all studies was 488 (IQR
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108–4099). Only six studies (three predicting complica-
tions, two improving prognostic models, and one pre-
dicting mortality) analysed data on more than 100,000
patients, while 35 analysed data on 10,000–100,000 pa-
tients, 18 (51.4%) of which attempted to predict mortality.
Most studies (211 [81.8%]) reported analyses of fewer than
10,000 patients. Large sample sizes (> 10,000 patients)
were most frequent in studies predicting complications,
mortality, or length of stay, and those aiming to improve
prognostic models or risk scoring systems. Sample sizes
were usually less than 1000 in studies determining physio-
logical thresholds or that aimed to detect spurious values.
Fig. 1 PRISMA 2009 flow diagram of study review process and exclusion of papers. From [11]
Table 1 Number and proportion of papers according to the aim of study and number of patients analysed
Number of patients analysed
Aim of study Number (%) of
papers with this
aima
< 100 100–1000 1000–10,000 10,000–100,000 100,000–1,000,000 Number not
reported
Predicting complications 79 (30.6%) 23 (29.1%) 26 (32.9%) 17 (21.5%) 8 (10.1%) 3 (3.8%) 2 (2.5%)
Predicting mortality 70 (27.1%) 11 (15.7%) 19 (27.1%) 19 (27.1%) 18 (25.7%) 1 (1.4%) 2 (2.9%)
Improving prognostic models/risk
scoring system
43 (16.7%) 8 (18.6%) 16 (37.2%) 8 (18.6%) 8 (18.6%) 2 (4.7%) 1 (2.3%)
Classifying sub-populations 29 (11.2%) 11 (37.9%) 8 (27.6%) 6 (20.7%) 2 (6.9%) 0 (0.0%) 2 (6.9%)
Alarm reduction 21 (8.14%) 9 (42.9%) 5 (23.8%) 7 (33.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Predicting length of stay 18 (6.98%) 3 (16.7%) 7 (38.9%) 5 (27.8%) 3 (16.7%) 0 (0.0%) 0 (0.0%)
Predicting health improvement 17 (6.59%) 5 (29.4%) 10 (58.8%) 2 (11.8%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Determining physiological thresholds 16 (6.20%) 10 (62.5%) 4 (25.0%) 1 (6.2%) 0 (0.0%) 0 (0.0%) 1 (6.2%)
Improving upon previous methods 5 (1.94%) 2 (40.0%) 1 (20.0%) 1 (20.0%) 1 (20.0%) 0 (0.0%) 0 (0.0%)
Detecting spurious recorded values 3 (1.16%) 1 (33.3%) 2 (66.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Total (accounting for duplicates) 258 72 (27.9%) 84 (32.6%) 55 (21.3%) 35 (13.6%) 6 (2.33%) 6 (2.33%)
aWhere papers had more than one aim, all aims were recorded, so percentages may total more than 100
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All further analyses were restricted to the 169 studies
that predicted at least one of four clearly definable types
of outcome: complications, mortality, length of stay, and
health improvement. MIMIC-II/III data were used in 45
(26.6%) of these 169 studies, a similar rate to the use of
MIMIC-II/III data in all outcomes (63 [24.4%]).
Type of machine learning
Among studies that predicted complications, mortality,
length of stay, or health improvement, 12 (7.1%) predicted
more than one of these types of outcome (Table 2). The
most commonly used types of machine learning were
neural networks (72 studies [42.6%]), support vector ma-
chines (40 [23.7%]), and classification/decision trees (34
[20.1%]). The median sample size was 863 (IQR 150–
5628). More than half of the studies analysed data on fewer
than 1000 patients. There were no strong associations
between the type of machine learning and size of dataset,
although the proportion of studies with sample sizes less
than 1000 was the highest for those using support
vector machines and fuzzy logic/rough sets. Machine
learning methods used in fewer than five papers were
combined under the “Other” category: of these. Data
on the machine learning methods used in the diffe-
rent types of prediction study are available from the
authors on request.
Machine learning studies using ICU data were published
from 1991 onwards (Fig. 2). The earliest studies were
based on fewer than 100 patients: the first studies based
on more than 1000, 10,000, and 100,000 patients were
published in 1996, 2001, and 2015 respectively. Although
study sizes have increased over time (among studies pub-
lished in 2017 and 2018, the median [IQR] sample size
was 3464 [286–21,498]), studies based on fewer than 1000
patients have been regularly published in recent years. Six
studies used data on more than 100,000 patients: one in
2015, one in 2017, and four in 2018 [2, 12–16].
The earliest machine learning studies all used neural
networks (Fig. 3). Papers using other machine learning
methods were reported from 2000 onwards, with support
vector machines reported from 2005 and random forests
from 2012. Of the 258 studies, 125 (48%) were published
from 2015 onwards. The most commonly reported ma-
chine learning approaches in these studies were support
vector machines (37 [29.6% of recent studies]), random
forests (29 [23.2%]), neural networks (31[24.8%]), and
classification/decision trees (27 [21.6%]).
Approaches to validation
Table 3 shows that of 169 studies that predicted compli-
cations, mortality, length of stay, or health improvement,
161 (95.2%) validated the predictions. Validations were
rarely based on independent data (10 studies [6.2%]).
The most commonly used approaches were to use ran-
dom subsets of the data with (71 [44.1%]) or without (71
[44.1%]) k-fold cross-validation respectively. Studies pre-
dicting the length of stay were most likely to use inde-
pendent data and least likely to use k-fold cross-validation.
Data on approach to validation according to the type of
machine learning and outcome predicted are available
from the authors on request.
Measures of predictive accuracy reported
The majority of the 161 papers that quantified the pre-
dictive accuracy of their algorithm reported the AUC
(97 [60.2%]), of which 43 (26.7%) papers also reported
accuracy, sensitivity, and specificity (Table 4). Sixty-two
studies (38.5%) reported these measures but not the
AUC. The AUC was most likely to be reported by stud-
ies predicting mortality (47 [69.1%]). Papers predicting
Table 2 Number and proportion of papers according to the type of machine learning used and number of patients analysed (for
prediction studies only)
Number of patients analysed
Type of machine learning Number (%) of
papers with this typea
< 100 100–1000 1000–10,000 10,000–100,000 100,000–1,000,000 Number not
reported
Neural network 72 (42.6%) 14 (19.4%) 27 (37.5%) 20 (27.8%) 9 (12.5%) 2 (2.8%) 0 (0.0%)
Support vector machine 40 (23.7%) 12 (30.0%) 15 (37.5%) 8 (20.0%) 4 (10.0%) 1 (2.5%) 0 (0.0%)
Classification/decision trees 35 (20.7%) 6 (17.1%) 11 (31.4%) 10 (28.6%) 5 (14.3%) 1 (2.9%) 2 (5.7%)
Random forest 21 (12.4%) 1 (4.8%) 9 (42.9%) 5 (23.8%) 4 (19.0%) 2 (9.5%) 0 (0.0%)
Naive Bayes/Bayesian networks 19 (11.2%) 4 (21.1%) 5 (26.3%) 6 (31.6%) 2 (10.5%) 1 (5.3%) 1 (5.3%)
Fuzzy logic/rough set 12 (7.1%) 3 (25.0%) 5 (41.7%) 2 (16.7%) 1 (8.3%) 0 (0.0%) 1 (8.3%)
Other techniquesb 28 (16.7%) 2 (7.1%) 10 (35.7%) 8 (28.6%) 7 (25.0%) 1 (3.6%) 0 (0.0%)
Total (accounting for duplicates) 169 37 (21.9%) 56 (33.1%) 42 (24.9%) 26 (15.4%) 4 (2.37%) 4 (2.37%)
aPapers can have more than one approach—percentages may total more than 100
bOther techniques (number of studies): causal phenotype discovery (1), elastic net (1), factor analysis (1), Gaussian process (2), genetic algorithm (1), hidden
Markov models (1), InSight (4); JITL-ELM (1), k-nearest neighbour (3), Markov decision process (1), particle swarm optimization (1), PhysiScore (1), radial domain
folding (1), sequential contrast patterns (1), Superlearner (4), switching linear dynamical system (1), Weibull-Cox proportional hazards model (1), method not
described (2)
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complications and health improvement were more likely
to report only accuracy, sensitivity, and specificity. All
18 papers predicting the numerical outcome of length of
stay validated their predictions: 8 (44.4%) reported the
proportion of variance explained (R2). There were 5 pa-
pers that reported the AUC dichotomized length of stay:
two papers at 1 day [17, 18], one at 2 days [19], one at 7
days [4], and one at 10 days [20]. Data on reported
measures of predictive accuracy according to the type of
machine learning and outcome predicted are available
from the authors on request.
Figure 4 shows the distribution of AUC according to
the size of dataset, for all prediction studies and for studies
predicting mortality or complications, with AUCs from the
10 studies that used external validation shown as individual
data points. The median AUC was higher in the smallest
studies (< 100 patients) which is likely to reflect over-opti-
mism arising from internal validation in small samples. The
median AUC increased with increasing sample size from
100 to 1000 patients to 100,000 to 1,000,000 patients. AUCs
for both a machine learning and a standard statistical ap-
proach were reported in only 12 studies (Fig. 5). For all but
one of these, the machine learning AUC exceeded that
from the standard statistical approach. However, the differ-
ence appeared related to the study size: three of the four
studies with substantial differences between the AUCs were
based on fewer than 1000 patients.
The proportion of papers reporting on calibration was
low: 30 (11.6%) of the 258 papers included in the review
and 23 (13.6%) papers of the 169 studies that predicted
complications, mortality, length of stay, or health im-
provement. Among these 23 papers, 21 reported Hosmer-
Lemeshow statistics [21], one reported the Brier score,
and one used a graphical approach.
Discussion
Key findings
Interest in the use of machine learning to analyse rou-
tinely collected ICU data is burgeoning: nearly half of
the studies identified in this review were published since
Fig. 3 Number of papers published according to the type of machine learning and year of publication
Fig. 2 Number of papers published according to the sample size and year of publication
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2015. Sample sizes, even in recently reported studies,
were often too small to exploit the potential of these
methods. Among studies that used machine learning to
predict clearly definable outcomes the most commonly
used methods were neural networks, support vector
machines, and classification/decision trees. Recently re-
ported studies were most likely to use support vector
machines, random forests, and neural networks. Most
studies validated their predictions using random subsets
of the development data, with validations based on inde-
pendent data rarely reported. Reporting of predictive ac-
curacy was often incomplete, and few studies compared
the predictive accuracy of their algorithm with that using
standard statistical methods.
Strengths and limitations
We used comprehensive literature searches but may
have omitted studies using proprietary machine learning
methods or code repositories that were not peer reviewed
and published in the literature databases searched. The
study was descriptive, and therefore, the risk of bias was
not assessed in the results of included studies. Robust
conclusions therefore cannot be drawn about the rea-
sons for the variation in AUC between studies or the
differences between the performance of machine learn-
ing prediction algorithms and those based on standard
statistical techniques. Although there were clear changes
in the machine learning techniques used with time, we did
not compare the performance of the different techniques.
Most of the analyses included in the review related to
studies that predicted the clearly definable outcomes of
complications, mortality, length of stay, or health im-
provement: quantitative conclusions about other types of
study were not drawn.
Results in context with literature
The last systematic review of the use of machine learn-
ing in the ICU was published in 2001 [9]. It noted the
particular suitability of the data-rich ICU environment
for machine learning and artificial intelligence. Further
narrative reviews stated the need to understand model
assumptions and methods to validate predictions when
conducting machine learning studies [21, 22]. Papers in
this review rarely compared the performance of machine
learning with that of predictions derived using standard
statistical techniques such as a logistic regression.
Empirical studies have suggested that standard statistical
techniques produce predictions that are often as accu-
rate as those derived using machine learnings [23].
Standard statistical techniques may have greater trans-
parency with regard to inputs, processing, and outputs:
the ‘black-box’ nature of machine learning algorithms
Table 3 Number and proportion of papers according to outcome predicted and approach to validation (for prediction studies only)
Approach to validationb
Outcome predicted Total papersa Validated Independent data Leave-P-out k-fold cross-validation Randomly selected subset Otherb
Complications 79 (46.7%) 73 (92.4%) 5 (6.85%) 5 (6.85%) 33 (45.2%) 30 (41.1%) 0 (0%)
Mortality 70 (41.4%) 68 (97.1%) 5 (7.35%) 3 (4.41%) 33 (48.5%) 27 (39.7%) 0 (0%)
Length of stay 18 (10.7%) 18 (100%) 3 (16.7%) 1 (5.56%) 4 (22.2%) 10 (55.6%) 1 (5.6%)
Health improvement 17 (10.1%) 16 (94.1%) 0 (0%) 1 (6.25%) 5 (31.2%) 10 (56.2%) 0 (0%)
Total (accounting for
duplicates)
169 161 (94.1%) 10 (6.2%) 8 (5%) 71 (44.1%) 71 (44.1%) 1 (0.6%)
aPapers can have more than one approach, so percentages may total more than 100
b“Other” techniques (number of studies): a comparison between ML and decisions made by clinicians (1)
Table 4 Number and proportion of papers according to outcome predicted and measure of predictive accuracy reported (for
studies that validated predictions)
Measure of predictive accuracy reporteda
Outcome predicted Total papers AUC and accuracy/sensitivity/specificity AUC only Accuracy/sensitivity/specificity only R2 Otherb
Complication 73 (45.3%) 24 (32.9%) 17 (23.3%) 28 (38.4%) 4 (5.5%)
Mortality 68 (42.2%) 16 (23.5%) 31 (45.6%) 18 (26.5%) 3 (4.4%)
Length of stay 18 (11.1%) 2 (11.8%) 3 (16.7%) 5 (27.8%) 8 (44.4%) 1 (5.6%)
Health improvement 16 (10%) 1 (6.3%) 3 (18.8%) 11 (68.8%) 1 (6.3%)
Total 161 43 (26.7%) 54 (33.5%) 62 (38.5%) 8 (5.0%) 9 (5.6%)
aPapers can have more than one approach, so percentages may total more than 100. The total of these columns does not account for duplicates as papers can
fluctuate how they discuss different results
b“Other” measures of predictive accuracy (number): congruence of ML and clinician’s decisions (1), Matthews correlation coefficient (1), mean absolute differences
between observed and predicted (1), mean error rate (1), MSE as loss function (1), Pearson correlation between estimate and actual (1), ratio of wins vs loses
against logistic regression (1), rules developed by ML (1)
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can make it difficult to understand the relative import-
ance of the different predictors and the way that they
contribute to predictions. This makes it difficult to
understand and correct errors when they occur. Thus,
studies have highlighted the desirability for transparent
reasoning from machine learning algorithms [24]. Our
review documents the evolving use of machine learning
methods in recent years, but the continuing limitations
in the conduct and reporting of the validation of these
studies still exist.
Figure 4 suggests that studies based on small sample
sizes and using internal validation overestimated model
performance. Although there are no fixed minimum
dataset sizes appropriate for machine learning applica-
tions, data on many tens or hundreds of thousands of
patients may be required for these approaches to realize
their potential and provide clear advantages over stand-
ard statistical analyses [25]. For dichotomous outcomes
such as in-hospital mortality, methods such as random
forests and support vector machines may demonstrate
instability and over-optimism even with more than 200
outcome events per variable [23]. However, the majority
of prediction studies included in our review analysed
data on fewer than 1000 patients, which is likely to be
too few to exploit the power of machine learning [6, 7].
Machine learning techniques are data hungry, and ‘over-
fitting’ is more likely in studies based on small sample
sizes. Achieving large sample sizes will require continu-
ing development of digital infrastructure that allows
linkage between databases and hence generation of data-
sets on large clinical populations [6, 16, 26]. Truly large
datasets (population sizes of > 100,000 individuals) have
so far been difficult to generate due to concerns over
data privacy and security. Sharing this data with large
commercial players who have the programming and pro-
cessing ability to extract multiple signals from that data
is even more difficult [27]. Only three papers included in
our review addressed use of machine learning to identify
data errors [28–30]. Errors are common in routine EHR
data [6], and thus, datasets must be cleaned before analyses.
Fig. 4 Boxplots showing the distribution of AUC scores according to the size of dataset, for all studies and separately for studies predicting
mortality and complications. Numbers displayed are the median AUC for each group. A cross indicates the AUC of one of the 10 papers using
independent test data. We did not plot results for studies predicting the length of stay and health improvement because the numbers of such
studies were small
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This represents one of the most important tasks in
using large datasets and is impossible to do without
automation.
Implications
The most rigorous approach to quantifying the likely
performance of machine learning algorithms in future
clinical practice, and avoiding over-optimism arising from
selection of variables and parametrizations, is to validate
algorithms using independent data [31]. However, this
was done in only a small minority of studies. Among stud-
ies that quantified predictive accuracy, most validated
their models using random subsets of their development
data. Because patterns of data in such test datasets do not
differ systematically from patterns in the training datasets,
they may overestimate model performance. A substantial
minority of studies did not validate predictions or report
the area under the ROC curve. Studies rarely discussed
the implementation of machine learning algorithms that
had been developed and whether they improved care.
They did not report new performance metrics that may
overcome limitations of the AUC, such as its insensitivity
to the number of false positives when predicting rare
events and that it gives equal weight to false positive and
false negative predictions [32, 33].
The papers included in our study generally focused on
discrimination (the ability to differentiate between pa-
tients who will and will not experience the outcome).
Few studies reported on calibration (the degree of agree-
ment between model predictions and the actual outcomes).
Model calibration is sensitive to shifts in unmeasured co-
variates and is particularly important when models are used
in population groups that are different from those used for
model development.
Reporting standards for applications of machine learn-
ing using routinely collected healthcare data, as well as
critical appraisal tools, might improve the utility of studies
in this area, as has been seen with randomized trials
(CONSORT), multivariable prediction models (TRIPOD),
and risk of bias in prediction studies (PROBAST) [34–39].
These might assist editors and peer reviewers, for example
by avoiding applications based on small datasets and
insisting that model performance is evaluated on either an
external dataset or, for studies using internal validation,
using a separate data subset or procedure appropriate to
compensate for statistical over-optimism. To ensure that
results are reproducible, and facilitate assessment of
discrimination and calibration in new settings, journals
and the academic community should promote access to
datasets and sharing of analysis code [40].
Conclusions
The increasing availability of very large and detailed data-
sets derived from routinely collected ICU data, and wide-
spread recognition of the potential clinical utility of
machine learning to develop predictive algorithms based
on these data, is leading to rapid increases in the number
of studies in this area. However, many published studies
are too small to exploit the potential of these methods.
Methodological, reporting, and critical appraisal guide-
lines, particularly with regard to the choice of method and
validation of predictions, might increase confidence in
reported findings and thereby facilitate the translation of
study findings towards routine use in clinical practice.
Fig. 5 Comparison of AUC scores found in complication or mortality prediction papers according to the technique used to produce them. A line
of equality is also provided
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